MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3

Biochemical and Biophysical Research Communications

Volumn 473, Issue 4, 2016, Pages 859-866

  Liu, Yuanhua ^a   Liu, Guanghui ^a   Zhang, Hui ^a   Wang, Jing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Calcium concentration; miR 199a 5p; Nitric oxide; Pulmonary artery hypertension; Smad3

Indexed keywords

CALCIUM; MICRORNA; MICRORNA 199A 5P; NITRIC OXIDE; SMAD3 PROTEIN; SMAD4 PROTEIN; UNCLASSIFIED DRUG; MIRN199 MICRORNA, HUMAN; SMAD3 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG PARENCHYMA; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; UPREGULATION; ANIMAL; GENETICS; LUNG; METABOLISM; PATHOPHYSIOLOGY; PULMONARY ARTERY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; CALCIUM; DOWN-REGULATION; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MICRORNAS; NITRIC OXIDE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; SMAD3 PROTEIN; TISSUE DISTRIBUTION;

EID: 84964955864     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.03.140     Document Type: Article

References (29)

1. N.F. Voelkel, J. Gomez-Arroyo, A. Abbate, H.J. Bogaard, and M.R. Nicolls Pathobiology of pulmonary arterial hypertension and right ventricular failure Eur. Respir. J. 40 2012 1555 1565
2. Z. Taimeh, J. Loughran, E.J. Birks, and R. Bolli Vascular endothelial growth factor in heart failure Nat. Rev. Cardiol. 10 2013 519 530
3. N. Galie, H.A. Ghofrani, A. Torbicki, R.J. Barst, L.J. Rubin, D. Badesch, T. Fleming, T. Parpia, G. Burgess, A. Branzi, F. Grimminger, M. Kurzyna, and G. Simonneau Sildenafil citrate therapy for pulmonary arterial hypertension N. Engl. J. Med. 353 2005 2148 2157
4. P. Caruso, M.R. MacLean, R. Khanin, J. McClure, E. Soon, M. Southgate, R.A. MacDonald, J.A. Greig, K.E. Robertson, R. Masson, L. Denby, Y. Dempsie, L. Long, N.W. Morrell, and A.H. Baker Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline Arterioscler. Thromb. Vasc. Biol. 30 2010 716 723
5. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
6. J. Bienertova-Vasku, J. Novak, and A. Vasku MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment J. Am. Soc. Hypertens. 9 2015 221 234
7. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, M. Harada, I. Shimizu, T. Asahara, H. Hamada, S. Tomita, J.D. Molkentin, Y. Zou, and I. Komuro p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
8. S. Mizuno, H.J. Bogaard, J. Gomez-Arroyo, A. Alhussaini, D. Kraskauskas, C.D. Cool, and N.F. Voelkel MicroRNA-199a-5p is associated with hypoxia-inducible factor-1alpha expression in lungs from patients with COPD Chest 142 2012 663 672
9. R. Roncarati, C. Viviani Anselmi, M.A. Losi, L. Papa, E. Cavarretta, P. Da Costa Martins, C. Contaldi, G. Saccani Jotti, A. Franzone, L. Galastri, M.V. Latronico, M. Imbriaco, G. Esposito, L. De Windt, S. Betocchi, and G. Condorelli Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 63 2014 920 927
10. P.D. Upton, R.J. Davies, T. Tajsic, and N.W. Morrell Transforming growth factor-beta(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3 Am. J. Respir. Cell Mol. Biol. 49 2013 1135 1145
11. T. Chen, G. Zhou, Q. Zhou, H. Tang, J.C. Ibe, H. Cheng, D. Gou, J. Chen, J.X. Yuan, and J.U. Raj Loss of microRNA-17 approximately 92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5 Am. J. Respir. Crit. Care Med. 191 2015 678 692
12. K.M. Drake, D. Zygmunt, L. Mavrakis, P. Harbor, L. Wang, S.A. Comhair, S.C. Erzurum, and M.A. Aldred Altered microRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8 Am. J. Respir. Crit. Care Med. 184 2011 1400 1408
13. B.N. Davis, A.C. Hilyard, P.H. Nguyen, G. Lagna, and A. Hata Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha Mol. Cell 39 2010 373 384
14. M.E. van Albada, R.G. Schoemaker, M.S. Kemna, A.H. Cromme-Dijkhuis, R. van Veghel, and R.M. Berger The role of increased pulmonary blood flow in pulmonary arterial hypertension Eur. Respir. J. 26 2005 487 493
15. M.P. Gupta, M.D. Ober, C. Patterson, M. Al-Hassani, V. Natarajan, and C.M. Hart Nitric oxide attenuates H(2)O(2)-induced endothelial barrier dysfunction: mechanisms of protection Am. J. Physiol. Lung Cell Mol. Physiol. 280 2001 L116 L126
16. L.H. Li, X.R. Tian, and Z.P. Hu The key target of neuroprotection after the onset of ischemic stroke: secretory pathway Ca(2+)-ATPase 1 Neural Regen. Res. 10 2015 1271 1278
17. L.C. Price, G. Caramori, F. Perros, C. Meng, N. Gambaryan, P. Dorfmuller, D. Montani, P. Casolari, J. Zhu, K. Dimopoulos, D. Shao, B. Girerd, S. Mumby, A. Proudfoot, M. Griffiths, A. Papi, M. Humbert, I.M. Adcock, and S.J. Wort Nuclear factor kappa-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension PLoS One 8 2013 e75415
18. S. Li, Y. Ran, D. Zhang, J. Chen, and D. Zhu MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1 Biochem. J. 452 2013 281 291
19. A. Sen, S. Ren, C. Lerchenmuller, J. Sun, N. Weiss, P. Most, and K. Peppel MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1 PLoS One 8 2013 e78684
20. S. Zhang, L. Liu, R. Wang, H. Tuo, Y. Guo, L. Yi, J. Wang, and D. Wang MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS Arch. Virol. 158 2013 2443 2452
21. X.W. Song, Q. Li, L. Lin, X.C. Wang, D.F. Li, G.K. Wang, A.J. Ren, Y.R. Wang, Y.W. Qin, W.J. Yuan, and Q. Jing MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes J. Cell Physiol. 225 2010 437 443
22. X.E. Shi, Y.F. Li, L. Jia, H.L. Ji, Z.Y. Song, J. Cheng, G.F. Wu, C.C. Song, Q.L. Zhang, J.Y. Zhu, and G.S. Yang MicroRNA-199a-5p affects porcine preadipocyte proliferation and differentiation Int. J. Mol. Sci. 15 2014 8526 8538
23. Y. Zhang, K.J. Fan, Q. Sun, A.Z. Chen, W.L. Shen, Z.H. Zhao, X.F. Zheng, and X. Yang Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-beta signalling pathway Nucleic Acids Res. 40 2012 9286 9297
24. J. Massagué, and D. Wotton Transcriptional control by the TGF-β/Smad signaling system EMBO J. 19 2000 1745 1754
25. A. Zakrzewicz, F.M. Kouri, B. Nejman, G. Kwapiszewska, M. Hecker, R. Sandu, E. Dony, W. Seeger, R.T. Schermuly, O. Eickelberg, and R.E. Morty The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension Eur. Respir. J. 29 2007 1094 1104
26. C. Chen, X. Han, F. Fan, Y. Liu, T. Wang, J. Wang, P. Hu, A. Ma, and H. Tian Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-beta1/Smad3-mediated fibrotic responses through 5-HT(2A) receptors Mol. Cell Biochem. 397 2014 267 276
27. R. Lafyatis Transforming growth factor beta-at the centre of systemic sclerosis Nat. Rev. Rheumatol. 10 2014 706 719
28. M. Shintani, H. Yagi, T. Nakayama, T. Saji, and R. Matsuoka A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension J. Med. Genet. 46 2009 331 337
29. S.S. Li, Y.J. Ran, D.D. Zhang, S.Z. Li, and D. Zhu MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K(+) channel in arterial smooth muscle cells J. Cell Biochem. 115 2014 1196 1205